Deltex Medical Ltd is delighted to be joining the ABHI UK Pavilion at MEDICA 2021 (November 15th -18th). The annual MEDICA show is Europe’s biggest healthcare industry event, with thousands of delegates heading to Dusseldorf from around the world. It’s an excellent forum at which to meet global partners, old and new. Deltex is always keen to tell the story behind its unique oesophageal Doppler monitoring(ODM+) technology as featured on the TrueVue haemodynamic monitoring platform.
Deltex CEO Andy Mears states; “At a time when operative surgery and critical care are facing unprecedented challenges, delivering the best possible outcomes has never been more in focus. Happily the evidence makes our case for us: ODM+ is supported by 24 randomised controlled trials. Indeed it is proven to dramatically reduce incidence of postoperative complications such as Acute Kidney Injury and Surgical Site Infection. Our evidence base is unique and separates ODM+ from all other haemodynamic monitoring technologies. Deltex’s experts are always delighted to show clinicians how to get the best from the system, and our technical expertise extends to our global partners. That’s one reason why it’s important to meet many of our partners at Medica. We’re also thrilled to have another opportunity to give our technology the publicity it deserves and as vehicles go they don’t get much bigger than Medica.”
